Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-04-21
1997-12-09
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514813, A61K 3155
Patent
active
056961154
ABSTRACT:
The invention provides a method for treating a condition resulting from the cessation and withdrawal of nicotine comprising administering an effective amount of
REFERENCES:
patent: 5229382 (1993-07-01), Chakrabarti et al.
patent: 5321012 (1994-06-01), Mayer et al.
HCAPLUS Abstract 1995: 752833 (1995) Corbett et al.
HCAPLUS Abstract 1993: 662437 (1993) Ando et al.
J. Gerlach, et al., "Intolerance to neuroleptic drugs: the art of avoiding extrapyramidal syndromes", European Psychiatry, 10:1, pp. 27S-31S (1994).
J. P. McEvoy, et al., "Clozapine Decreases Drive to Smoke", VIIth Biennial European Workshop on Schizophrenia, Les Diablerets, Switzerland, Jan. 23-28, 46:5 (1994), Poster 28.
N. A. Moore, et al., "The Behavioral Pharmacology of Olanzapine, a Novel Atypical Antipsychotic Agent", J. Pharm. Exp. Ther., 262:2, pp. 545-551 (1992).
Boone David E.
Cintins Marianne M.
Eli Lilly and Company
Moezie M.
Vorndran-Jones MaCharri
LandOfFree
Method for treating nicotine withdrawal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating nicotine withdrawal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating nicotine withdrawal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1607865